Biofrontera Share Price - BFRA

0.0949 (1.73%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Biofrontera AG BFRA NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.0949 1.73% 5.5849 09:48:58
Open Price Low Price High Price Close Price Prev Close
5.42 5.42 5.64 5.49
Bid Price Ask Price Spread News
5.58 5.65 0.07 - -
Trades Volume VWAP Dollar Volume Avg Volume
19 768  5.49  4,219 65,947
Last Trade Time Type Quantity Stock Price Currency
09:49:44 7  5.5941 USD

Biofrontera Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 133.33M 23.87M 23.87M  35.08M  -20.26M -0.36 -10.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - 0.00% - -

more financials information »

News Biofrontera

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

BFRA Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.
3 Years0.
5 Years0.

Biofrontera AG is active in the field of healthcare in the United Kingdom. It manufactures pharmaceutical products, especially medical cosmetics and dermatological drugs for the care and treatment of skin diseases. Its suite of products includes the prescription drugs Ameluz and BF-RhodoLED, for the treatment of actinic keratosis and Belixos, for the regenerative care of reddened and inflamed skin.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.